Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112863 · ClinicalTrials.gov registry record · Early Phase 1
Comparison of the Cosmetic Effects of Bakuchiol and Retinol
A Early Phase 1 study of Wrinkle and Photoaging, sponsored by University of California, Davis.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT03112863: Completed Early Phase 1 study of Wrinkle and Photoaging, sponsored by University of California, Davis.
NCT03112863 is a Early Phase 1 study of Wrinkle and Photoaging that has completed, run by University of California, Davis. The registered enrollment target is 44 participants, below the 118-participant average among 25 other Wrinkle trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03112863, a Early Phase 1 study of Wrinkle and Photoaging, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects will be assigned to a retinoid cream or bakuchiol to compare the cosmetic effects. This will take place over a 12 week period.
Primary Outcome
Assessed using image analysis based assessment of wrinkle severity (depth and length). The primary outcome measure was image-analysis-based assessment of wrinkle severity and pigmentation at 12 weeks.
Conditions Studied
Interventions
- DRUG Bakuchiol
- DRUG Retinol
Study Locations (1)
California
- UC Davis Department of Dermatology - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2017-03-24 |
| Est. Completion | 2019-03-01 |
| Phase | Early Phase 1 |
What the finished NCT03112863 record still lists
NCT03112863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 118-participant average among 25 other Wrinkle trials with a reported enrollment target (63% lower).
The record links to 2 conditions, with Wrinkle appearing as the primary indexed condition, and to 2 interventions - of which Bakuchiol is the first listed.
NCT03112863 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03112863 about?
NCT03112863 is a clinical study titled "Comparison of the Cosmetic Effects of Bakuchiol and Retinol". Subjects will be assigned to a retinoid cream or bakuchiol to compare the cosmetic effects. This will take place over a 12 week period.
What is the current status of trial NCT03112863?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 44 participants. The study started on 2017-03-24. Estimated completion is 2019-03-01.
What conditions does trial NCT03112863 study?
This clinical trial studies the following conditions: Wrinkle, Photoaging.
What interventions are being tested in trial NCT03112863?
The interventions under investigation include: Bakuchiol (DRUG), Retinol (DRUG).
Who is sponsoring clinical trial NCT03112863?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03112863 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03112863's enrollment target sits among peer trials
44 13th of 25 higher than 13 of 25 other Wrinkle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wrinkle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
RECRUITING
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI